1.Research Method on Content Determination of Strychnine and Brucine in Rat Plasma
Tianchao CHEN ; Li LI ; Qichao LIANG ; Wei CHENG
World Science and Technology-Modernization of Traditional Chinese Medicine 2015;(11):2341-2348
This study was aimed to establish an effective method for the simultaneous content determination of strychnine and brucine in rat plasma.The Wistar rat plasma samples were processed by liquid-liquid extraction and separated on a UPLC BEH C18 column.The mobile phase was acetonitrile - acid water (17?83).The acid water was 0.02 mol·L-1.The potassium dihydrogen phosphate and 0.014 8 mol·L-1 sodium heptane sulfonate was mixed with equal amount.The 10% phosphonic acid was used to adjust the system to the pH of 2.8.The detection wavelength was set at 260 nm.The results showed that foreign materials in the Wistar rat plasma did not interfere with the content determination of samples.The calibration curve of strychnine was in good linearity within the range of 0.067 84-3.392 00μg·mL-1.The calibration curve of brucine was in good linearity with the range of 0.052 48-2.624 00μg·mL-1.The intra-and inter-day precisions were less than 10%.The mean extraction recoveries were more than 85%.The stability results met the requirements for biopharmaceutical analysis.It was concluded that the UPLC detection method was sensitive and precise,which can be used in the pharmacokinetics study of strychnine and brucine in Tong-Mai(TM) pill.
2.Construction of risk evaluation indicators for the occurrence of diaphragm dysfunction in ICU patients
Yunfeng BAI ; Tianchao CHEN ; Xinyi LIU ; Yueying FENG ; Hongbo LUO ; Zunzhu LI ; Jianhua SUN ; Jing CAO ; Haibo DENG ; Xinjuan WU
Chinese Journal of Nursing 2024;59(11):1339-1345
Objective The risk evaluation indicators for the occurrence of diaphragm dysfunction in ICU patients was constructed to provide a reference for the establishment of the disease risk evaluation tools for diaphragm dysfunction.Methods The literature related to diaphragm dysfunction from CNKI,Wanfang Data,PubMed,Embase and Web of Science from the establishment of databases to November 11 th,2022 was systematically searched.After the first draft was determined through the literature review method,the first draft of the indicators was revised by brainstorming,with the opinions of 10 medical and nursing experts from May to June 2023.From June to July 2023,the content and weight of risk evaluation indicators of diaphragmatic dysfunction in ICU patients were determined through expert letter inquiry and hierarchical analysis.Results 35 experts completed the first round of letter inquiry,and 34 experts completed the second round of letter inquiry.The recovery rates of the valid questionnaires in the 2 rounds of expert correspondence were 92.1%and 97.1%,respectively,and the expert authority coefficients were 0.884 and 0.904,respectively,and the Kendall harmony coefficients of all indicators were 0.356~0.570 and 0.369~0.604,respectively(all P<0.001).The final constructed risk evaluation indicators of diaphragm dysfunction in ICU patients includes 7 first-level indicators,34 secondary indicators and 34 tertiary indicators.Conclusion The risk evaluation index of diaphragm dysfunction in ICU patients constructed in this study is comprehensive,specific,scientific and applicable,which can guide medical staff to conduct early risk evaluation of diaphragm function in ICU patients,and provide references for the establishment of disease risk assessment tools for diaphragm function.
3.Analysis of the Inclusion of Set Prescription Preparation Containing Coptis chinensis and Its Processed Product in 2015 Edition of Chinese Pharmacopeia ·Guidelines for Clinical Drug Use
Yanjiang MA ; Lanlan YU ; Jiao WANG ; Tianchao CHEN
China Pharmacy 2019;30(10):1343-1347
OBJECTIVE: To provide reference for standardizing rational use of set prescription preparation containing Coptis chinensis and its processed product. METHODS: By retrieving 2015 edition of Chinese Pharmacopeia·Guidelines for Clinical Drug Use(volume of TCM set prescription), the inclusion of set prescription preparation containing C. chinensis and its processed product were summarized and analyzed. RESULTS&CONCLUSIONS: There were 127 set prescription preparations containing C. chinensis and its processed product included in 2015 edition of Chinese Pharmacopeia·Guidelines for Clinical Drug Use(volume of TCM set prescription), among which, there were 83, 5, 2, 8, 4, 11, 6, 5 and 3 set prescription preparations for internal medicine, surgery, gynecology, pediatrics, dermatology, ophthalmology, pharyngology, stomatology, orthopedics and traumatology, respectively. There were 120 set prescription preparations containing C. chinensis(94.49%), 2, 4 and 1 set prescription preparations containing prepared C. chinensis with vino, prepared C. chinensis with ginger and prepared C. chinensis with Euodia rutaecarpa, respectively. There were 39, 59 and 29 kinds of set prescription preparations with C. chinensis as main symptoms medicine, assists medicine and complication medicine, which were mainly for clearing heat, drying dampness, purging fire and detoxifying(104 kinds, 81.89%). Main types included Shexiang niuhuang pills, Gegen cenlian tablets, Kaiwei jianpi pills, etc. By comparing the efficacy of C. chinensis and its processed product, it was found that the names of processed products were not standardized, the labeling of C. chinensis and its processed products were not uniform and the application was not standardized; the related contents still needed to be further improved. It is necessary to strengthen the research on the pharmacodynamic basis and processing standard of C. chinensis and carry out the investigation and correction of relevant publications in order to help improve the rational drug use level of set prescription preparations containing C. chinensis and its processed products.
4.Correlation Analysis on the Content of Main Components,Physical Parameters and the Color of Fructus Sophorae in Nine-steam-nine-bask Processing
Xiaojing NIU ; Chang SU ; Jing LU ; Yanjiang MA ; Yangli GENG ; Tianchao CHEN
Traditional Chinese Drug Research & Clinical Pharmacology 2024;35(8):1236-1245
Objective To analyze the correlation of the main chemical components,physical parameters and the color of Fructus Sophorae in nine-steam-nine-bask processing.Methods The contents of sophoracin,genistein,rutin and 5-hydroxymethylfurfural were simultaneously determined by high performance liquid chromatography(HPLC).The content of polysaccharide was determined by ultraviolet spectrophotometry.The correlation of main components,physical parameters and the color was studied by the measurement of the physical parameters and the color(L*、a*、b*)combined with hierarchical cluster analysis(HCA),principal component analysis(PCA)and partial least squares(PLS).The criteria importance through intercriteria correlation(CRITIC)method was used to make a comprehensive evaluation of the nine-steam-nine-bask processing of Fructus Sophorae.Results The methods for the content determination and chromaticity measurement were accurate and reliable.The precision,stability and repeatability tests were good.The results of HCA and PCA showed that Fructus Sophorae,which was steamed-basked for one to four times,could be grouped into one category.Fructus Sophorae steamed-basked for five to nine times were classified into another category.PLS correlation analysis showed that the contents of polysaccharide and rutin were significantly correlated with physical parameters and color.The water absorption expansion and relative density were significantly correlated with the color.The comprehensive evaluation showed that nine-steam-nine-bask Fructus Sophorae was the best.Conclusion There is certain regularity in the overall changes of the content of main components,physical parameters and the color of Fructus Sophorae during nine-steam-nine-bask processing.The combination of the internal components,the color and physical parameters provides the basis for revealing the mechanism on nine-steam-nine-bask processing of Fructus Sophorae.
5.Interpretation of Standard for Prescription-based Processing of Chinese Herbal Pieces
Yanjiang MA ; Xinjing GUI ; Fengyu DONG ; Jing LU ; Jing YAO ; Ruixin LIU ; Tianchao CHEN ; Xuelin LI
Herald of Medicine 2024;43(7):1046-1049
To promote the development of the prescription-based processing of Chinese herbal pieces,the China Association of Chinese Medicine published the social organization standard of the Standard for Prescription-based Processing of Chinese Herbal Pieces(T/CACM 1367-2021)in June 2021.The standard was led by the First Affiliated Hospital of Henan University of Chinese Medicine and Jiangsu Province Hospital of Chinese Medicine.It was jointly drafted by 28 Traditional Chinese medical institutions across the country.This paper introduced the standards in detail to promote the implementation and propel the inheritance and innovation of the processing of Chinese herbal pieces.